HIT Consultant November 30, 2022
Jinhan Kim, Co-founder and CEO, Standigm

Repetitive behavioral disorders such as obsessive-compulsive disorder (OCD), Tic Disorder and Tourette Syndrome have been challenging to treat because they involve considerable complexity. For example, the symptoms of one disorder can vary among individuals as does the coexistence or non-existence of other behavior disorders such as anxiety and depression. Further, the treatment of OCD, Tic Disorder and Tourette Syndrome varies depending on the disorders present in an individual patient, how long the disorder’s traits have been present, how individual patients respond to treatment dosages and the efficacy of treatment.

Historically and even modernly, medical professionals have found themselves faced with an array of potential treatments that may or may not work alone or in combination with other drugs. Compounding the...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: AI (Artificial Intelligence), Biotechnology, Pharma, Pharma / Biotech, Technology
‘Think about the hype’ - AI holds disruptive potential for health care
Will Synthetic, AI-Based Digital Humans Change Pharma and Life Sciences? Q&A with Abid Rahman, SVP Innovation, EVERSANA
Investigators Train AI Systems to Predict RA Outcomes
Confronting the Digital Dilemma in Healthcare’s Quest for Innovation
NIH develops AI tool to better pair cancer patients with drugs

Share This Article